Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Pancreatic cancer: a state of emergency?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy
Hongli Jiang et al.
PHARMACOLOGICAL RESEARCH (2020)
Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art
Sally A. El-Zahaby et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth
Paige J. Bothwell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
Jianxin Ye et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo
Jian Lu et al.
ONCOTARGET (2017)
Endogenous glutamine decrease is associated with pancreatic cancer progression
Cecilia Roux et al.
ONCOTARGET (2017)
Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer
V. Coothankandaswamy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma
Hiroaki Honjo et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
Hong-Wei Sun et al.
PLOS ONE (2016)
Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
Qian Wang et al.
JOURNAL OF PATHOLOGY (2015)
Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma
Osamu Nikkuni et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma
Kyoichi Kaira et al.
HISTOPATHOLOGY (2015)
ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation
Ping Ren et al.
JOURNAL OF PATHOLOGY (2015)
Targeting glutamine transport to suppress melanoma cell growth
Qian Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Mohamed Hassanein et al.
CLINICAL CANCER RESEARCH (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
Dania Daye et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
Simon Rieder et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake
Valentina K. Todorova et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent
Chitta Ranjan Patra et al.
CANCER RESEARCH (2008)
ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells
Bryan C. Fuchs et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Glutamine and glutamate as vital metabolites
P Newsholme et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
